New limits for personal injury and wrongful death lawsuits may become a reality in Texas
A proposal to limit how much an accident victim can recover in lawsuits for medical care won preliminary approval from the Texas House on Monday, but not without changes that leave open monetary awards beyond medical bills and preserve the court's ability to decide what evidence is relevant.
The bill passed 94-52 on Monday with the support of at least five Democrats.
Senate Bill 30, authored by Georgetown Republican Sen. Charles Schwertner, intends to curb 'nuclear verdicts,' or jury rulings that award victims more than $10 million, which proponents say makes doing business in Texas unpredictable.
If the proposal becomes law, those who sue in personal injury or wrongful death cases can submit only the amount paid for medical services, and directs juries to limit the amount of damages based on a set of options such as the maximum that can be charged to Medicare.
The bill was a priority of Texans for Lawsuit Reform, a well-funded group representing oil and energy companies that has spent the last two decades trying to curb what they see as frivolous lawsuits.
For the bill to become law, the House must vote on it again. Then the Senate must agree to changes, or request a committee hash out differences.
At a committee hearing in April, business owners shared their experiences of getting sued in accidents where the damage appeared minimal — according to poster-sized photos they brought to the hearing — but the damages sought were in the millions.
Opponents argued that there's already an appeals process in the civil lawsuit process that parties can use to reduce the damages owed.
The bill overcame resistance from some conservative activists who previously supported the efforts by Texas for Lawsuit Reform's namely, restricting medical malpractice lawsuits.
The version of the bill that passed the House removed language that drew concern from opponents, such as a provision that would have barred juries from awarding money for 'noneconomic damages' such as mental anguish. That was raised by some accident victims and sexual assault survivors who said the impacts of their injuries could not be placed neatly into the economic damage categories the previous version of the bill outlined.
On the House floor Monday, lawmakers also approved an amendment by Rep. Greg Bonnen, R-Friendsburg, who is carrying the bill in the House, to remove a portion of the bill that would have only allowed damages on services that have health care industry billing codes, which not all services an accident victim needs would have.
Another Bonnen amendment changed the requirement for an itemized list by the provider of a plaintiff to a summary list. Lawmakers unsuccessfully tried to further narrow that requirement, though an amendment by Rep. Matt Morgan, R-Richmond, reaffirming privacy protections between doctors and patients, and attorneys and clients was adopted.
A pair of amendments by Reps. Mitch Little, a Lewisville Republican, and Joe Moody, an El Paso Democrat, also passed, over the objection of Bonnen, to no longer require some evidence related to medical history be automatically admitted. The amended bill leaves it to a judge to decide whether the evidence is relevant – something Bonnen said defeated the purpose of that part of the bill.
The Texas Trial Lawyers Association, which lobbied for months against the bill, said the changes since it was first introduced were a sign of how Texans felt about efforts to curb lawsuits.
'This result sends a clear message that Texans of all walks of life support the fundamental value of accountability embodied in our civil justice system,' Jack Walker, president of the association, said in a statement.
Disclosure: Texans for Lawsuit Reform and Texas Trial Lawyers Association have been financial supporters of The Texas Tribune, a nonprofit, nonpartisan news organization that is funded in part by donations from members, foundations and corporate sponsors. Financial supporters play no role in the Tribune's journalism. Find a complete list of them here.
First round of TribFest speakers announced! Pulitzer Prize-winning columnist Maureen Dowd; U.S. Rep. Tony Gonzales, R-San Antonio; Fort Worth Mayor Mattie Parker; U.S. Sen. Adam Schiff, D-California; and U.S. Rep. Jasmine Crockett, D-Dallas are taking the stage Nov. 13–15 in Austin. Get your tickets today!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
8 minutes ago
- Los Angeles Times
Can Elon Musk get Tesla back on track? Here are four road bumps
After a tumultuous months-long period by President Trump's side, Elon Musk is turning his attention back to his companies, including the stumbling electric vehicle maker Tesla Inc. Musk announced on X last week that his time as a special government employee was over. Tesla investors welcomed the news, hoping that Musk's departure from Washington would boost his car company's reputation and lagging performance. Since Musk began his role leading the White House advisory team called the Department of Government Efficiency in January, Tesla's stock has fallen roughly 12%. On Tuesday, the shares closed at $332, down 3.5%. The Austin, Texas-based company — which has a significant manufacturing operation in Fremont, Calif., and is the dominant EV company in the state — has been the subject of protests and vandalism as Musk, the company's chief executive, aligned himself with Trump and made controversial spending cuts on behalf of the federal government. The brand damage spread outside the U.S. to Europe, where monthly sales in 32 countries fell nearly 50% in April. 'It was very important for Musk to end this chapter and start working on Tesla's next stage of growth,' Wedbush Securities analyst Dan Ives said. 'Now he can get back to what he's supposed to be doing.' As the executive shifts his focus back to Tesla, here are four challenges experts say he must tackle: By associating himself with the president and the Trump administration's erratic actions, Musk alienated a large swath of his customers. Many Tesla drivers are liberal-leaning, industry analysts said, and were drawn to the company's environmental mission to take gas cars off the road. In protest over Musk's activities, some Tesla drivers, including celebrities, began selling or getting rid of their vehicles. Others sported new bumper stickers that said, 'I bought this before we knew Elon was crazy.' In February, Tesla topped the list of brands that lost the most resale value year over year, according to data provided by Karl Brauer, an analyst with The price of a used Tesla Model S and Model Y each dropped by about 16% in February from a year earlier. 'Price is a reflection of supply and demand,' Brauer said. 'So it could be that nobody wants to buy them anymore, or that there's a massive influx of them available, or both.' Now that he's left Washington, Musk will have to prove that his attention is on Tesla and that he isn't prioritizing political agendas. Ives estimated that about 5% to 10% of the brand damage sustained during Musk's stint in the capital will be permanent. 'Tesla has become a political symbol around the world and that's not a good thing,' said Ives, who has an 'outperform' rating on Tesla's stock. 'But there are much brighter days ahead now that Musk is no longer in the White House.' Musk has made lofty promises for years about the capabilities of Tesla's self-driving technology and plans for a robotaxi service. Though he has often over-exaggerated his progress, Musk has taken important steps toward commercializing autonomous driving technology. The future of his company depends on whether he can follow through, experts said. 'Musk's top priority should be autonomy and robotics,' Ives said. 'With these technologies, I believe Tesla's market cap could reach $2 trillion.' The company is currently valued at just over $1 trillion. According to claims Musk has made, Tesla drivers will one day be able to sleep in their car as it drives them across the country. Tesla's robotaxis will roam city streets, and humanoid robots dubbed Optimus will perform everyday tasks. Brauer compared the emergence of autonomous driving technology to a change on the scale of the internet or smartphones. But it's still far off, he said. Although the driverless taxi company Waymo is already operating in a few cities including Santa Monica, it could take 10 to 15 years for the technology to become widely accessible and integrated into society, Brauer said. Tesla remains the dominant force in the electric vehicle market, but rapidly increasing competition from traditional carmakers and other EV manufacturers have thinned sales, Brauer said. Major manufacturers including Ford and Chevy have released lines of their own electric vehicles, while promising startups such as Irvine-based Rivian have cut into Tesla's market share. At the same time, demand for electric vehicles is plateauing as the market gets saturated, Brauer said. Tesla's profit plummeted 71% in the first quarter to $409 million as the company faced a flurry of setbacks, including a falloff in automotive sales and rising competition. To keep up and remain viable, Tesla will have to reassess aspects of its business model. 'Many people, I think including Musk himself, have realized that the current business model is pretty much played out,' Brauer said. 'He's not going to substantially increase his revenue and his profit selling these same electric cars.' Tesla could receive a boost in sales if it successfully launched an affordable model accessible to more customers, but despite rumors and claims by executives, a release date has not been announced. The company could be further hurt by the loss of a $7,500 federal electric vehicle credit, which encourages sales and is likely to be eliminated by the Trump administration. While chargers for electric vehicles are ubiquitous in many parts of California, infrastructure is lacking throughout large areas of the country — and that's a problem. For the U.S. to rely more heavily on EVs, significant progress has to be made on the network of charging stations, Brauer said. Finding a time and place to charge is an obstacle for many Tesla drivers and limits the range of customers Tesla can reach. The lack of a fully comprehensive charging network would also hinder Musk's plans to operate a nationwide robotaxi service, Brauer said. In California, many chargers are broken or have been intentionally damaged by protesters.
Skift
9 minutes ago
- Skift
Making Sense of the JetBlue and United Partnership
We sort the speculation from the facts, contextualize the JetBlue-United deal, and ask what it really means for the carriers and the wider industry. For this episode of the Airline Weekly Lounge, hosts Gordon Smith and Jay Shabat delve into the recently announced partnership between JetBlue and United Airlines. They discuss the implications of this collaboration, the financial struggles faced by JetBlue, and the potential benefits for both airlines. The conversation also touches on regulatory considerations and industry reaction. Listen to This Podcast Apple Podcasts | Spotify | YouTube | RSS Takeaways
Medscape
15 minutes ago
- Medscape
GLP-1 Users Should Fast 24 Hours Before Anesthesia
Patients taking the new class of weight-loss drugs do not need to stop these medications prior to procedures requiring anesthesia, but they should adhere to longer preoperative fasting times, according to a new multidisciplinary consensus statement. The statement, led by the Society for Perioperative Assessment and Quality Improvement, recommends patients without significant gastrointestinal symptoms associated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) should fast from solid foods for 24 hours and stick to clear liquids prior to a procedure requiring anesthesia. This extended fasting time can help mitigate aspiration risk in these patients with delayed gastric emptying while retaining the benefits of continuing GLP-1 RAs, such as improved glycemic control. The statement is 'the first to provide recommendations for perioperative management of patients taking GLP-1 RAs based on an in-depth systematic literature review of both clinical perioperative studies and gastric emptying data,' Adriana Oprea, MD, the first author of the document, and her colleagues wrote. Changing Guidance In June 2023, the American Society of Anesthesiologists (ASA) released the first guidance statement regarding preoperative management of patients on GLP-1 RAs, after some case reports documented aspiration events in these patients. While the number of these events is generally low and rates of aspiration appear to be similar between patients on GLP-1 RAs and the general population, 'people got really worried with these drugs because of [the] delayed gastric emptying,' Oprea, an associate professor of anesthesiology at Yale School of Medicine in New Haven, Connecticut, told Medscape Medical News . The 2023 ASA guidance recommended holding GLP-1 RAs for one half-life — a week for patients on long-acting medication and a day for short-acting GLP-1s. Due to a lack of adequate evidence at the time, the document suggested these patients should follow the standard ASA fasting guidelines of 8 hours after a full meal. However, evidence suggests stopping GLP-1s for one half-life is not enough for the effects on gastric emptying to subside, according to the new statement. For longer-acting drugs like dulaglutide, semaglutide, and tirzepatide, patients would need to discontinue these medications for several weeks to restore normal gastrointestinal motility. For patients with type 2 diabetes, discontinuation of these medications over this period could lead to poor glycemic control, which is linked to worse postoperative outcomes. For patients taking GLP-1 RAs for weight loss, restarting these medications can result in increased gastrointestinal symptoms, Oprea said, such as nausea, vomiting, diarrhea, or constipation. 'Because adverse effects are more prevalent at higher GLP-1 RA doses, discontinuation of these medications might lead to a high likelihood of side effects upon medication reinitiation or require reinitiation of therapy at lower doses followed by dose reescalation,' Oprea's group wrote. 'This is logistically difficult for both patients and treating clinicians.' In October 2024, the ASA, along with other professional societies, published updated practice guidance stating GLP-1 RAs may be continued preoperatively in patients without an elevated risk for delayed gastric emptying and aspiration. Those defined as 'higher risk' included patients in the escalation phase, on weekly dosing, on higher doses, and with gastrointestinal symptoms. The guidance advised these patients at higher risk for delayed stomach emptying can help mitigate aspiration risk by following a 24-hour liquid diet. This updated guidance also received some criticism. 'As of yet, no studies have reported a difference in the incidence of increased residual gastric content that would justify treating patients differently on the basis of dose regimen and/or treatment phase,' wrote Glenio B. Mizubuti, MD, PhD, of the Kingston General Hospital, in Kingston, Ontario, Canada, and his colleagues in a letter to Anesthesiology . 'Similarly, the absence of ongoing digestive symptoms, while somewhat reassuring, should not be taken as a definitive sign of an empty stomach in GLP-1 RA users,' they wrote. Continue Meds, Extend Fasting Times This new consensus statement, published last month in the British Journal of Anaesthesia , recommends patients doing well on GLP-1 RAs should continue these medications preoperatively and follow a clear liquid diet for 24 hours before procedures requiring anesthesia. The recommendations were based on a systematic review of 112 studies and a modified Delphi process and were co-sponsored and endorsed by the American Association of Clinical Endocrinology. 'From our review of the literature, we feel that the fasting times are the most important factor that could decrease the risk of having residual gastric content in the stomach in a patient on GLP-1 RAs when they're scheduled to have a procedure that requires anesthesia,' Oprea said. The consensus also recommends patients on GLP-1s fast from high-carbohydrate-content clear liquids (containing 10% or more glucose) for 8 hours before and stop drinking any liquids four hours before these procedures. Inpatient and outpatients can restart GLP-1 RAs when they resume their original diets. Patients with significant gastrointestinal symptoms including severe nausea, vomiting, and inability to tolerate oral intake should postpone elective procedures that require anesthesia and refer to their prescribing physician for diet and medication modifications to manage symptoms, the authors advised. 'Our recommendation for a clear liquid diet for 24 hours preprocedurally might appear overly restrictive. However, evidence points to the safety of this approach in patients on GLP-1 RAs,' they wrote.
